The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
A 6-month prospective survey of cutaneous drug reactions in a hospital setting
Abstract
BACKGROUND: Few prospective studies are available on the incidence and analysis of the characteristics of adverse cutaneous drug reactions in hospital settings. OBJECTIVES: A 6-month prospective study was managed in our hospital among hospitalized patients to: (i) evaluate the incidence of cutaneous allergic reactions from systemic drugs; (ii) study characteristics of patients with cutaneous drug reactions; (iii) describe the adverse cutaneous reactions; and (iv) evaluate drug reaction imputability and preventability. METHODS: All suspected allergic cutaneous reactions to systemic drugs were collected during a 6-month period (November 2000 to May 2001). Exhaustivity of recording was ensured by regular dissemination of information about this study to the practitioners; a simple method for inclusion by fax was established. Inclusion criteria were suspected cutaneous allergic reactions induced by systemic drugs responsible for hospitalization or developed during hospitalization. A physical examination was done by a dermatologist who completed a standardized questionnaire. Requested information included patient characteristics (associated disorders, severity score), drug intake (list and chronology of the drug intake during the 3 weeks preceding the adverse reaction) and characteristics of the skin reaction (type, course). A group comprising dermatologists and pharmacologists evaluated the drug imputability and preventability. RESULTS: Forty-eight cases were collected. A prevalence of 3.6/1000 among hospitalized patients was estimated. The prevalence rate was higher in patients hospitalized in medical departments (0.5%) than in surgical departments (0.01%) (P < 0.001). The cases were mostly recruited in departments of infectious diseases and dermatology. The most frequent associated disorders were: human immunodeficiency virus (HIV) infection (19%), connective tissue disease (10%) and viral or autoimmune hepatitis (12%). Of these patients, 31% had had a previous immunological drug reaction. Adverse cutaneous drug reactions were principally exanthematous (56%). Reactions were considered severe in 34% of cases because they were responsible for hospitalization (18%), increased the duration of hospitalization (14%) or were life threatening (2%). Principal imputable drugs were antibiotics, mainly penicillins. An imputability score was likely in 56% of cases, but it was only possible to conclude definitively in 44% of patients. In 15% of the cases, the side-effect was considered to be preventable. CONCLUSIONS: This study finds a lower incidence than other studies that reported an incidence of 2% of cutaneous drug reactions in hospitalized patients, but only allergic adverse cutaneous reactions induced by systemic drugs were collected in this study. The previous studies were principally done in selected patients hospitalized only in general internal medicine or medical divisions. Our results confirm some data already known about skin drug reactions: HIV infection as a risk factor (P < 0.0001), high prevalence of adverse cutaneous reactions due to antibiotics, and difficulty in ascertaining the imputability of a drug. A high proportion (34%) of these reactions was severe and 15% were avoidable; these two facts justify the development of an intensive programme of clinical pharmacology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bégaud, B., Evreux, J. C., Jouglard, J., & Lagier, G. (1985) · PubMed · Cited by 966
Arndt, K. A. (1976) · JAMA · doi:10.1001/jama.235.9.918 · Cited by 484
Do Women Have More Adverse Drug Reactions?
Rademaker, M. (2001) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200102060-00001 · Cited by 432
Descamps, V., Valance, A., Edlinger, C., Fillet, A., Grossin, M., Lebrun‐Vignes, B., Bélaïch, S., & Crickx, B. (2001) · PubMed · Cited by 358
Self-citationDrug-related illness in emergency department patients
Dennehy, C. E., Kishi, D. T., & Louie, C. (1996) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/53.12.1422 · Cited by 95
Cited by
The DRESS Syndrome: A Literature Review
Cacoub, P., Musette, P., Descamps, V., Meyer, O., Speirs, C., Finzi, L., & Roujeau, J. C. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.01.017 · Cited by 1,012
Self-citationHusain, Z., Reddy, B. Y., & Schwartz, R. A. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.01.033 · Cited by 489
Epidemiology of hypersensitivity drug reactions
Gomes, E. R., & Demoly, P. (2005) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/01.all.0000173785.81024.33 · Cited by 410
Epidemiology and risk factors for drug allergy
Thong, B. Y., & Tan, T. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03774.x · Cited by 393
Gruchalla, R. S., & Pirmohamed, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp043986 · Cited by 204
Metadata
- Authors
- Fiszenson-Albala, F., Auzerie, V., Mahe, E., Farinotti, R., Durand-Stocco, C., Crickx, B., & Descamps, V.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-11
- Volume
- 149
- Issue
- 5
- Pages
- 1018-1022
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W2017306702
- Cited by
- 283
- References
- 6
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A 6-month prospective survey of cutaneous drug reactions in a hospital setting. https://app.cochat.ai/papers/10.1111/j.1365-2133.2003.05584.x
- The paper
- Fiszenson-Albala, F., Auzerie, V., Mahe, E., Farinotti, R., Durand-Stocco, C., Crickx, B., & Descamps, V. (2003). A 6-month prospective survey of cutaneous drug reactions in a hospital setting. British Journal of Dermatology. https://doi.org/10.1111/j.1365-2133.2003.05584.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.